Overview
US health insurer's Q1 adjusted revenue beat analyst expectations
Adjusted income from operations per share rose 16% to $7.79
Company raised 2026 outlook for adjusted income from operations per share
Outlook
Cigna raises 2026 adjusted income from operations outlook to at least $30.35 per share
Company sees 2026 Evernorth pre-tax adjusted income from operations of at least $6.9 bln
Cigna Healthcare 2026 pre-tax adjusted income from operations outlook raised to at least $4.525 bln
Cigna expects 2026 Cigna Healthcare medical care ratio of 83.7% to 84.7%
Result Drivers
EVERNORTH GROWTH - Evernorth Health Services revenue and operating income rose, driven by specialty pharmacy volume and increased adoption of generics and biosimilars
CIGNA HEALTHCARE MARGINS - Improved margins in U.S. Healthcare drove higher operating income, despite lower revenue from the HCSC divestiture
OPERATING EFFICIENCY - Lower SG&A expense ratios reflected business mix shift and improved operating efficiency
Company press release: ID:nPn9YWqVna
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$68.49 bln
Q1 Adjusted Revenue
Beat
$68.52 bln
$66.37 bln (18 Analysts)
Q1 EPS
$6.26
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy"
Wall Street's median 12-month price target for Cigna Group is $334.00, about 14.3% above its April 29 closing price of $292.32
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)